Enliven Therapeutics Inc (ELVN)

Apr 10, 2026

Enliven Therapeutics (ELVN) soars to 5-year high as analysts 'upbeat' - MSN

Apr 10, 2026

Apr 09, 2026

(ELVN) Volatility Zones as Tactical Triggers - Stock Traders Daily

Apr 09, 2026

Apr 09, 2026

ELVN Surges Amid Strategic Acquisition Talks and Analyst Upgrades - StocksToTrade

Apr 09, 2026

Apr 08, 2026

H.C. Wainwright reiterates Enliven Therapeutics stock rating on Terns deal details - Investing.com Canada

Apr 08, 2026

Apr 07, 2026

Merck’s Acquisition Ups Competition in Pharmaceuticals, Enliven Shines - timothysykes.com

Apr 07, 2026

Apr 07, 2026

Merck’s Acquisition Sparks Surge in Enliven Therapeutics - StocksToTrade

Apr 07, 2026

Apr 07, 2026

Enliven Therapeutics Regains Attention as Stock Prices Soar - timothysykes.com

Apr 07, 2026

Apr 07, 2026

Enliven Therapeutics stock hits 52-week high at $40.66 - Investing.com

Apr 07, 2026

Apr 07, 2026

Enliven Therapeutics stock hits 52-week high at $40.66 By Investing.com - Investing.com South Africa

Apr 07, 2026

Apr 06, 2026

Enliven (ELVN) gets higher price targets from HC Wainwright and Mizuho - MSN

Apr 06, 2026

Apr 06, 2026

Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho - Insider Monkey

Apr 06, 2026

Apr 05, 2026

Terns Buyout Deal Ignites Optimism For Enliven Therapeutics’s Blood Cancer Portfolio - MSN

Apr 05, 2026

Apr 05, 2026

5 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey

Apr 05, 2026

Apr 03, 2026

Enliven Therapeutics stock hits 52-week high at 30.29 USD - Investing.com

Apr 03, 2026

Mar 31, 2026

25,000-share resale via Jefferies — Enliven Therapeutics (NASDAQ: ELVN) - Stock Titan

Mar 31, 2026

Mar 31, 2026

[144] Enliven Therapeutics, Inc. SEC Filing - Stock Titan

Mar 31, 2026

Mar 30, 2026

Q1 EPS Estimate for Enliven Therapeutics Reduced by Analyst - MarketBeat

Mar 30, 2026

Mar 30, 2026

Assessing Enliven Therapeutics (ELVN) Valuation After Strong Recent Share Price Momentum - Yahoo Finance

Mar 30, 2026

Mar 29, 2026

Price-Driven Insight from (ELVN) for Rule-Based Strategy - Stock Traders Daily

Mar 29, 2026

Mar 29, 2026

Enliven Therapeutics CMO Executes $1.2M Stock Sale | Company Update 2026News and Statistics - IndexBox

Mar 29, 2026

Mar 28, 2026

Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million - AOL.com

Mar 28, 2026

Mar 27, 2026

Volume Report: Should I trade or invest in Enliven Therapeutics Inc2026 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Enliven Therapeutics Insider Sold Shares Worth $1,404,024, According to a Recent SEC Filing - MarketScreener

Mar 27, 2026

Mar 27, 2026

Enliven (NASDAQ: ELVN) CMO exercises options and sells 40K shares - Stock Titan

Mar 27, 2026

Mar 27, 2026

Aug PreEarnings: Can Enliven Therapeutics Inc disrupt its industryDip Buying & Low Volatility Stock Recommendations - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Enliven Therapeutics (NASDAQ:ELVN) Price Target Raised to $56.00 at HC Wainwright - Defense World

Mar 27, 2026

Mar 26, 2026

ELVN Stock Soars as Merck’s Billion-Dollar Acquisition Validates Strategy - timothysykes.com

Mar 26, 2026

Mar 26, 2026

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Terns Pharmaceuticals (TERN) - The Globe and Mail

Mar 26, 2026

Mar 26, 2026

Enliven Therapeutics (NASDAQ:ELVN) Given New $56.00 Price Target at HC Wainwright - MarketBeat

Mar 26, 2026

Mar 26, 2026

Enliven Therapeutics stock price target raised to $56 by H.C. Wainwright - Investing.com Canada

Mar 26, 2026

Mar 26, 2026

Enliven Therapeutics (NASDAQ:ELVN) Hits New 12-Month High on Analyst Upgrade - MarketBeat

Mar 26, 2026

Mar 25, 2026

Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’ - Insider Monkey

Mar 25, 2026

Mar 25, 2026

Enliven Reports Q4 Loss; Clinical Milestones Ahead - timothysykes.com

Mar 25, 2026

Mar 25, 2026

Enliven Therapeutics (ELVN) affiliate files to sell 45,000 shares via Jefferies - Stock Titan

Mar 25, 2026

Mar 25, 2026

Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Up After Analyst Upgrade - marketbeat.com

Mar 25, 2026

Mar 25, 2026

Enliven Therapeutics (NASDAQ:ELVN) Gains Attention After Price Target Adjustment - kalkinemedia.com

Mar 25, 2026

Mar 25, 2026

Enliven Therapeutics (NASDAQ:ELVN) Price Target Raised to $45.00 - MarketBeat

Mar 25, 2026

Mar 25, 2026

Clear Street reiterates Enliven Therapeutics stock Buy on CML opportunity By Investing.com - ca.investing.com

Mar 25, 2026

Mar 25, 2026

Enliven Therapeutics stock surges 28% on Merck-Terns deal By Investing.com - Investing.com Canada

Mar 25, 2026

Mar 25, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market SessionAkari Therapeutics (NASDAQ:AKTX), Artelo - Benzinga

Mar 25, 2026

Mar 24, 2026

ELVN Surges 12%: Clinical Milestone Breaks Barriers and Sparks Biotech Momentum - Bitget

Mar 24, 2026

Mar 24, 2026

Mizuho raises Enliven Therapeutics price target to $45 on CML data - Investing.com Canada

Mar 24, 2026

Mar 24, 2026

Enliven Therapeutics (Nasdaq: ELVN) founder files Form 144 to sell 100,000 - Stock Titan

Mar 24, 2026

Mar 20, 2026

Enliven Therapeutics (NASDAQ:ELVN) Hits New 12-Month HighShould You Buy? - MarketBeat

Mar 20, 2026

Mar 19, 2026

Enliven Therapeutics stock hits 52-week high at $30.98 By Investing.com - Investing.com Canada

Mar 19, 2026

Mar 19, 2026

Enliven Therapeutics CMO Collins sells $138,800 in stock By Investing.com - Investing.com Australia

Mar 19, 2026

Mar 19, 2026

Enliven Therapeutics CMO Collins sells $138,800 in stock - Investing.com

Mar 19, 2026